Area of research
Pulmonary and Respiratory Medicine · Cancer Research
Research interest
Research interests include Ferroptosis and cancer prognosis, RNA modifications and cancer, Cancer-related molecular mechanisms research, and Cancer Immunotherapy and Biomarkers.
Translational medicine for acute lung injury
A genome-wide association study of neonatal metabolites
Comparison of <scp>breast‐conserving</scp> surgery without radiotherapy and mastectomy in the treatment of elderly patients with early breast cancer: A <scp>PSM</scp> and <scp>SEER</scp> database study
miR-3587 Inhibitor Attenuates Ferroptosis Following Renal Ischemia-Reperfusion Through HO-1
The application of mixed reality to sentinel lymph node biopsy in breast cancer Running title: Application of mixed reality in breast cancer
Molecular subtypes based on ferroptosis-related genes and tumor microenvironment infiltration characterization in lung adenocarcinoma
Prognostic biomarker TUBA1C is correlated to immune cell infiltration in the tumor microenvironment of lung adenocarcinoma
Comparative Study of Acute Lung Injury in COVID-19 and Non-COVID-19 Patients
NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
Prognostic model of lung adenocarcinoma constructed by the CENPA complex genes is closely related to immune infiltration
Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
Clinicopathological features and genomic profiles of hepatoid adenocarcinoma of the lung: Report of four cases
Comprehensive study of a novel immune-related lncRNA for prognosis and drug treatment of cervical squamous cell carcinoma.
PubMed 2021cited by 10position: middle
Malignant melanotic Xp11 neoplasms exhibit a clinicopathologic spectrum and gene expression profiling akin to alveolar soft part sarcoma: a proposal for reclassification
Overexpression of TPX2 predicts poor clinical outcome and is associated with immune infiltration in hepatic cell cancer
Molecular and Immune Characteristics for Lung Adenocarcinoma Patients With ERLIN2 Overexpression
Association of higher axillary pathologic complete response rate with breast pathologic complete response after neoadjuvant chemotherapy
Overexpression of fibronectin type�III domain containing�3B is correlated with epithelial‑mesenchymal transition and predicts poor prognosis in lung adenocarcinoma
A combination of LMO2 negative and CD38 positive is useful for the diagnosis of Burkitt lymphoma
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy
The expression level and prognostic value of HIPK3 among non-small-cell lung cancer patients in China
Lepidic component at tumor margin: an independent prognostic factor in invasive lung adenocarcinoma
Spondin-2 is a novel diagnostic biomarker for laryngeal squamous cell carcinoma
Combination of cadherin-17 and SATB homeobox 2 serves as potential optimal makers for the differential diagnosis of pulmonary enteric adenocarcinoma and metastatic colorectal adenocarcinoma
miR-1236-3p suppresses the migration and invasion by targeting KLF8 in lung adenocarcinoma A549 cells
KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker
Spondin2 is a new prognostic biomarker for lung adenocarcinoma
PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast
Expression of Kruppel-like factor 8 and Ki67 in lung adenocarcinoma and prognosis
Krüppel-Like Factor 8 Overexpression Correlates with Poor Prognosis in Non-Small Cell Lung Cancer